Inventor
MANNING JAMES R
US13 patents
⚠️ This page may combine multiple inventors who share the name “MANNING JAMES R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
12 patentsUS11098051B2Aug 24, 2021
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
NOVARTIS AG5 citations82
US10160764B2Dec 25, 2018
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
NOVARTIS AG11 citations82
US11453677B2Sep 27, 2022
Tricyclic compounds useful to treat orthomyxovirus infections
NOVARTIS AG2 citations71
US10858366B2Dec 8, 2020
Tricyclic compounds useful to treat orthomyxovirus infections
NOVARTIS AG3 citations71
US9688672B2Jun 27, 2017
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
NOVARTIS AG2 citations71
US11629149B2Apr 18, 2023
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
NOVARTIS AG3 citations70
US11912715B2Feb 27, 2024
Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
NOVARTIS AG0 citations60
US12071441B2Aug 27, 2024
10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
NOVARTIS AG0 citations59
US12172984B2Dec 24, 2024
Pyrazolopyridine derivatives and uses thereof
NOVARTIS AG0 citations57
US12252482B2Mar 18, 2025
Pyrazolopyridine derivatives and uses thereof
NOVARTIS AG0 citations56
US11787785B2Oct 17, 2023
Pyrazolopyridine derivatives and uses thereof
NOVARTIS AG0 citations56
US10112931B2Oct 30, 2018
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
NOVARTIS AG0 citations51